These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 341073)

  • 21. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 23. Special considerations for the development of drugs for acute clinical mastitis.
    Mercer HD; Teske RH
    J Am Vet Med Assoc; 1977 May; 170(10 Pt 2):1190-4. PubMed ID: 873834
    [No Abstract]   [Full Text] [Related]  

  • 24. Description of two Serratia marcescens associated mastitis outbreaks in Finnish dairy farms and a review of literature.
    Friman MJ; Eklund MH; Pitkälä AH; Rajala-Schultz PJ; Rantala MHJ
    Acta Vet Scand; 2019 Nov; 61(1):54. PubMed ID: 31727124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on mastitis. III. Mastitis therapy.
    Francis PG
    Br Vet J; 1989; 145(4):302-11. PubMed ID: 2673482
    [No Abstract]   [Full Text] [Related]  

  • 26. [The study of selected factors of virulence in Serratia marcescens (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jan; 31(1):55-63. PubMed ID: 6460566
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serratia liquefaciens mastitis in a dairy herd.
    Bowman GL; Hueston WD; Boner GJ; Hurley JJ; Andreas JE
    J Am Vet Med Assoc; 1986 Oct; 189(8):913-5. PubMed ID: 3771362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis.
    Morin DE; Shanks RD; McCoy GC
    J Am Vet Med Assoc; 1998 Sep; 213(5):676-84. PubMed ID: 9731263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995).
    Pyörälä SH; Pyörälä EO
    J Am Vet Med Assoc; 1998 Feb; 212(3):407-12. PubMed ID: 9470054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute bovine mastitis caused by Clostridium perfringens, type A (author's transl)].
    Engebretsen O; Karset HA
    Nord Vet Med; 1973 Nov; 25(11):580-3. PubMed ID: 4360450
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serratia marcescens].
    Alés Reinlein JM; Cid AT; Cachon García F
    Rev Clin Esp; 1971 Oct; 123(2):129-32. PubMed ID: 4945145
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro antibiotic susceptibility of E. coli isolated from acute and chronic bovine mastitis with reference to clinical efficacy.
    Søgaard H
    Nord Vet Med; 1982; 34(7-9):248-54. PubMed ID: 6757854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)].
    Hartemann P; Imbs MA; Blech MF
    Immun Infekt; 1979 Aug; 7(4):134-9. PubMed ID: 227782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statistical observation of urinary tract infections by Serratia marcescens].
    Kamiryo Y; Sakatoku J
    Hinyokika Kiyo; 1983 Apr; 29(4):401-10. PubMed ID: 6203384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of exchange transfusion and directed antibiotic therapy in the treatment of severe sepsis. A case of multi-resistant Serratia marcescens sepsis].
    Agnese G; Raddo S
    Minerva Pediatr; 1978 May; 30(9):753-7. PubMed ID: 351366
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serratia marcescens, a microbial species with potential pathogenicity and increasing clinical importance].
    Bârzu AO; Bârzu N; Ciureanu A
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):67-72. PubMed ID: 397588
    [No Abstract]   [Full Text] [Related]  

  • 38. [Spiramycin and the antibacterial therapy of mastitis].
    Verheijden JH; Vecht U; van Leeuwen W; van Miert AS
    Tijdschr Diergeneeskd; 1984 Jul; 109(13):554-6. PubMed ID: 6464000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibacterial drug effectiveness against mastitis pathogens.
    Huber WG
    J Am Vet Med Assoc; 1977 May; 170(10 Pt 2):1182-4. PubMed ID: 873831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.